TickerFactsScreenerDevelopers

Gain Therapeutics, Inc. (GANX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$3.48M2021: -$13.83M2022: -$17.78M2023: -$22.25M2024: -$20.35M2025: -$18.71M-$18.71M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$18.71M+8.1%
2024-$20.35M+8.5%
2023-$22.25M-25.2%
2022-$17.78M-28.6%
2021-$13.83M-297.4%
2020-$3.48M—